Walker Marlan D, CEO of TherapeuticsMD ($TXMD), made three open market purchases of common shares totaling $2,483 over the last 365 days, with the most recent on April 14, 2025. These buys rank 4,723rd among 4,983 insiders in our database, where the average purchase amount is $1.46 million across 3.29 transactions on average. Walker Marlan D reported no open market sales in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 3, 2025 | TherapeuticsMD, Inc. | $TXMD | Walker Marlan D | Chief Executive Officer | A | Non-Qualified Stock Option (right to buy) | 67492 | $0.00 | 67,492.0000 | 11,574,000 | 9999.99% | 0.58% |
| April 14, 2025 | TherapeuticsMD, Inc. | $TXMD | Walker Marlan D | Chief Executive Officer | P | Common Stock | 490 | $1.00 | 73,639.0000 | 11,552,000 | 0.67% | 0.00% |
| April 10, 2025 | TherapeuticsMD, Inc. | $TXMD | Walker Marlan D | Chief Executive Officer | P | Common Stock | 1167 | $0.86 | 73,149.0000 | 11,552,000 | 1.62% | 0.01% |
| April 9, 2025 | TherapeuticsMD, Inc. | $TXMD | Walker Marlan D | Chief Executive Officer | P | Common Stock | 1136 | $0.87 | 71,982.0000 | 11,552,000 | 1.60% | 0.01% |
| Feb. 18, 2025 | TherapeuticsMD, Inc. | $TXMD | Walker Marlan D | Chief Executive Officer | M | Common Stock | 2311 | $0.00 | 68,343.0000 | 11,532 | 3.50% | 20.04% |
| Feb. 18, 2025 | TherapeuticsMD, Inc. | $TXMD | Walker Marlan D | Chief Executive Officer | M | Common Stock | 770 | $0.00 | 69,113.0000 | 11,532 | 1.13% | 6.68% |
| Feb. 18, 2025 | TherapeuticsMD, Inc. | $TXMD | Walker Marlan D | Chief Executive Officer | M | Common Stock | 1733 | $0.00 | 70,846.0000 | 11,532 | 2.51% | 15.03% |
| Feb. 18, 2025 | TherapeuticsMD, Inc. | $TXMD | Walker Marlan D | Chief Executive Officer | M | Performance Stock Units | 3467 | $0.00 | 0.0000 | 11,532 | 100.00% | 30.06% |
| Feb. 18, 2025 | TherapeuticsMD, Inc. | $TXMD | Walker Marlan D | Chief Executive Officer | M | Restricted Stock Units | 2311 | $0.00 | 0.0000 | 11,532 | 100.00% | 20.04% |
| Feb. 18, 2025 | TherapeuticsMD, Inc. | $TXMD | Walker Marlan D | Chief Executive Officer | M | Restricted Stock Units | 770 | $0.00 | 0.0000 | 11,532 | 100.00% | 6.68% |
| Feb. 18, 2025 | TherapeuticsMD, Inc. | $TXMD | Walker Marlan D | Chief Executive Officer | M | Restricted Stock Units | 1733 | $0.00 | 1,733.0000 | 11,532 | 50.00% | 15.03% |
| Feb. 18, 2025 | TherapeuticsMD, Inc. | $TXMD | Walker Marlan D | Chief Executive Officer | M | Common Stock | 3467 | $0.00 | 66,032.0000 | 11,532 | 5.54% | 30.06% |